Abbott announced, early Monday morning, that it had signed a deal to purchase Belgium-based drug manufacturer Solvay Pharmaceuticals for $6.6 billion in cash—a mere five months after Solvay’s CEO Werner Cautreels announced that the company was searching for a proper suitor.
The deal adds more than $3 billion in annualized sales to its global pharmaceutical business—three-quarters [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Abbott to Purchase Solvay for $6.6 Billion (Update 1)